No surprises, no recalls all good

Given the way things have been going this week with the Medtronic recall and the Insulet notice it’s refreshing that the Dexcom earnings announcement had no surprises. Yes as Momma Kliff used to say surprises can be fun but dull isn’t so bad either. Although we wouldn’t exactly classify Dexcom’s earnings as dull as the company continues to click on all cylinders. If anything one has to wonder with their stock surging ahead can it sustain this momentum.

While there were several positive takeaways from the earnings and call the biggest was the continued progress . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.